CHM-1 is a microtubule-destabilizing agent that inhibits tubulin polymerization; it exhibits potent and selective antimitotic and antitumor activity against human hepatocellular carcinoma; CHM-1 induces G2-M phase arrest in human hepatocellular carcinoma cells by activating Cdc2 kinase activity, leading to growth inhibition and apoptosis.